Companies submitting electronic adverse reaction reports to the Danish Medicines Agency in the period from 1 December up to and including 6 December are advised that the electronic acknowledgement will be delayed. The delay is caused by the implementation of a new adverse reaction database (pharmacovigilance database).
Companies should expect to receive the delayed acknowledgements from 7 December.
For further information, please contact the Danish Medicines Agency on +45 4488 9595 or E2B@dkma.dk.
Danish Medicines Agency, 29 November 2010